NIMBEX 5 mg/ml, solution for injection/for infusion bottle, 30 ml
Active ingredients: BÉSILATE DE CISATRACURIUM, CISATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusionbottle, 30 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIMBEX 5 mg/ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 30 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1997
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60224800CIP75595392CIP133400955953920Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CISATRACURIUMsolution | 5 mg · 1 ml | FT |
| BÉSILATE DE CISATRACURIUMsolution | 6,70 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BESILATE DE CISATRACURIUM équivalant à CISATRACURIUM 5 mg/ml - NIMBEX 5 mg/ml, solution injectable/pour perfusion